These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16640990)

  • 1. [ACE inhibitors and AT-II antagonists--do they protect against renal disease?].
    Rossing P; Parving HH
    Ugeskr Laeger; 2006 Apr; 168(15):1564; author reply1564-5. PubMed ID: 16640990
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T; Takizawa S
    Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
    Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renoprotective effect of Blood pressure control on progression of diabetic retinopathies].
    Katayama S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():389-93. PubMed ID: 15999740
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-receptor blockade in renal disease: the hard issues.
    Sica DA
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):469-71. PubMed ID: 15225107
    [No Abstract]   [Full Text] [Related]  

  • 6. Best practice for hypertensive patients with kidney disease.
    de Zeeuw D
    Hosp Med; 2003 Feb; 64(2):96-100. PubMed ID: 12619337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.
    Saelen MG; Prøsch LK; Gudmundsdottir H; Dyrbekk D; Helge Hunderi O; Arnesen E; Paulsen D; Skjønsberg H; Os I
    Blood Press; 2005; 14(3):170-6. PubMed ID: 16036497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK; Epstein M
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J
    Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract]   [Full Text] [Related]  

  • 10. ACE inhibitors vs. ARBs for patients with diabetic kidney disease.
    Bailey J
    Am Fam Physician; 2007 Jul; 76(1):68-9. PubMed ID: 17668841
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
    Hirsch S
    Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood pressure goal and antihypertensive therapy in chronic kidney disease].
    Rump LC
    Dtsch Med Wochenschr; 2014 Nov; 139(48):2453-7. PubMed ID: 25409404
    [No Abstract]   [Full Text] [Related]  

  • 13. ACE inhibitors and ARBs: antihypertensive medications in CKD.
    Szromba C
    Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
    [No Abstract]   [Full Text] [Related]  

  • 14. ARBs vs ACE inhibitors for preventing diabetic nephropathy.
    Greenwood V
    J Fam Pract; 2005 May; 54(5):453; discussion 453-4. PubMed ID: 15865904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renoparenchymal hypertension].
    Mühlhauser I; Sawicki P; Berger M
    Dtsch Med Wochenschr; 1989 Apr; 114(17):689-90. PubMed ID: 2707137
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New therapeutic options in renal diseases--hypotensive therapy].
    Gaciong Z
    Pol Arch Med Wewn; 2004 Oct; 112 Spec No():57-63. PubMed ID: 15669202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The road to renal failure: an overview of diabetic nephropathy.
    McCrary EB
    Adv Nurse Pract; 2008 Jul; 16(7):61-3. PubMed ID: 19181161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetic nephropathy--manage now!].
    Ritz E
    Dtsch Med Wochenschr; 2010 Mar; 135(9):p8. PubMed ID: 20200822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.